NDC 70710-1052

ATAZANAVIR

Atazanavir

ATAZANAVIR is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Zydus Pharmaceuticals (usa) Inc.. The primary component is Atazanavir Sulfate.

Product ID70710-1052_81c3dde0-7b49-4ebd-bf60-a2d6b81759ba
NDC70710-1052
Product TypeHuman Prescription Drug
Proprietary NameATAZANAVIR
Generic NameAtazanavir
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2021-05-04
Marketing CategoryANDA /
Application NumberANDA210575
Labeler NameZydus Pharmaceuticals (USA) Inc.
Substance NameATAZANAVIR SULFATE
Active Ingredient Strength300 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70710-1052-1

100 CAPSULE in 1 BOTTLE (70710-1052-1)
Marketing Start Date2021-05-04
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ATAZANAVIR" or generic name "Atazanavir"

NDCBrand NameGeneric Name
42385-920AtazanavirAtazanavir
42385-921AtazanavirAtazanavir
42385-922AtazanavirAtazanavir
59762-0408ATAZANAVIRATAZANAVIR
59762-0409ATAZANAVIRATAZANAVIR
59762-0410ATAZANAVIRATAZANAVIR
69097-443ATAZANAVIRAtazanavir
69097-444ATAZANAVIRAtazanavir
69097-445ATAZANAVIRAtazanavir
69097-446ATAZANAVIRATAZANAVIR
69238-1135AtazanavirAtazanavir
69238-1136AtazanavirAtazanavir
69238-1137AtazanavirAtazanavir
69238-1138AtazanavirAtazanavir
70518-2832ATAZANAVIRATAZANAVIR
0904-6875Atazanavir SulfateAtazanavir
16714-860Atazanavir SulfateAtazanavir
16714-861Atazanavir SulfateAtazanavir
16714-862Atazanavir SulfateAtazanavir
60687-399Atazanavir SulfateAtazanavir
65862-710Atazanavir SulfateAtazanavir
65862-711Atazanavir SulfateAtazanavir
65862-712Atazanavir SulfateAtazanavir
65862-713Atazanavir SulfateAtazanavir
0003-3622REYATAZATAZANAVIR
0003-3624REYATAZATAZANAVIR
0003-3631REYATAZATAZANAVIR
0003-3638REYATAZATAZANAVIR
50090-1007REYATAZATAZANAVIR
50090-1581REYATAZATAZANAVIR

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.